Ginkgo Bioworks Holdings Inc DNA

US Life Sciences Tools & Services

$10.66 ▲ +4.00% (+$0.41)

⬆️ Above Yest. High

Open $10.20

Prev Close $10.25

Day Range $9.54 – $10.67

52W Range $5.37 – $17.58

Market Cap $717.85M

Beta 1.78

EPS (TTM) $-5.00

📋 Company Profile

Industry	Life Sciences Tools & Services
Country	US
Exchange	NEW YORK STOCK EXCHANGE, INC.
Currency	USD
IPO Date	2021-04-19
Shares Out.	62,320,000
Website	investors.ginkgobioworks.com/ ↗
Phone	18774425362
Employees	485
Revenue	$20.2M
Gross Profit	$18.4M
Net Income	-$46.7M
Free Cash Flow	-$174.8M
Total Assets	$990.0M
Total Liabilities	$569.8M
Equity	$420.3M

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Ginkgo Bioworks Holdings Inc is a publicly traded company under the ticker symbol DNA on the NEW YORK STOCK EXCHANGE, INC., operating in the Life Sciences Tools & Services industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.